If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOsirium Tech Regulatory News (OSI)

  • This share is currently suspended. It was suspended at a price of 2.20

Share Price Information for Osirium Tech (OSI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.20
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 0.00
OSI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Full Year Trading Update

9 Jan 2023 07:00

RNS Number : 0007M
Osirium Technologies PLC
09 January 2023
 

The information contained within this announcement is deemed by the Company to constitute inside information pursuant to Article 7 of EU Regulation 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 as amended.

 

 

9 January 2023

 

Osirium Technolgies plc

("Osirium", the "Group" or the "Company")

 

 

Full Year Trading Update

 

Osirium Technologies plc (AIM: OSI), a leading vendor of cloud-based cybersecurity software, today provides an update on the trading for the financial year ended 31 December 2022 ahead of its audited final results.

 

The Board is pleased to announce that, subject to completion of the audit, it expects to report bookings and revenue for the 12 months to 31 December 2022 of at least £3.0 million (2021: £1.6 million) and £1.9 million (2021: £1.4 million) respectively, in line with recently upgraded market expectations.

 

Osirium's annual recurring revenue ("ARR") for December 2022 was £1.8 million, an increase of 28% over the prior financial year (December 2021 ARR: £1.4million), and deferred revenue at 31 December 2022 was £2.7 million, providing the Group good visibility as it starts the new financial year. Following the placing and subscription, announced on 22 November 2022, the cash balance as at 31 December 2022 was £1.1 million.

 

Osirium has continued to maintain its rate of customer acquisition in 2022, with new customers signed from an increasing range of sectors and geographies, including a first contract signed in the US. Alongside this, the Group's average initial contract value for new customers increased by 93% over the course of the year, reflecting a recognition across the Group's target sectors and geographies of the need to fortify their cybersecurity defences over the long term.

 

In addition to its core Privileged Access Management ("PAM") product, there has been a considerable growth in demand for Osirium's Privileged Process Automation and Privileged Endpoint Management products in the year, both as standalone products to new customers and as add-ons to PAM contracts. Looking ahead to 2023, the Group continues to focus on growing the services it delivers to its customers through cross-selling and upselling, while expanding its customer base through new customer acquisition.

 

Stuart McGregor, Chief Executive Officer of Osirium, commented:

 

"2022 was another year of progress against our financial and strategic objectives, in which we have succeeded in growing our average contract value and securing more multi-year contracts, which provide a good visibility of revenue for future years and a greater opportunity for up-selling and cross-selling our products and services".

 

"Our momentum in customer acquisition has continued in the second half and our sales pipeline underpins our confidence going into the new financial year. We are confident we have the right teams in place across our direct sales channel and our global channel partner network to continue to expand our presence across new and existing sectors and geographies.

 

"As stated at the time of our fundraise in November, the Board's focus is on reducing the timeframe to the Company becoming cash flow break-even through revenue growth and tight cost control. With an expanded customer base, an innovative product suite and healthy demand for privileged security, we approach 2023 with confidence in the Group's growth prospects."

 

 

Contacts:

Osirium Technologies plc

Tel: +44 (0)1183 242 444

Stuart McGregor, Chief Executive Officer

Rupert Hutton, Chief Financial Officer

Allenby Capital Limited (Nominated adviser and broker)

Tel: +44 (0)20 3328 5656

James Reeve / George Payne (Corporate Finance)

Tony Quirke (Sales and Corporate Broking)

Alma PR (Financial PR adviser)

Tel: +44 (0)20 3405 0205

Hilary Buchanan

osirium@almapr.co.uk

Kieran Breheny

Will Ellis Hancock

 

About Osirium Technologies Plc

 

Osirium Technologies plc (AIM: OSI) is a leading UK-based cybersecurity software vendor delivering Privileged Access Management (PAM), Privileged Endpoint Management (PEM) and Osirium Automation solutions that are uniquely simple to deploy and maintain.

 

With privileged credentials involved in over 80% of security breaches, customers rely on Osirium PAM's innovative technology to secure their critical infrastructure by controlling 3rd party access, protecting against insider threats, and demonstrating rigorous compliance. Osirium Automation delivers time and cost savings by automating complex, multi-system processes securely, allowing them to be delegated to Help Desk engineers or end-users and to free up specialist IT resources. The Osirium PEM solution balances security and productivity by removing risky local administrator rights from users, while at the same time allowing escalated privileges for specific applications.

 

Founded in 2008 and with its headquarters in Reading, UK, the Group was admitted to trading on AIM in April 2016. For further information please visit www.osirium.com.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFIDLDIRIIV
Date   Source Headline
15th Oct 20207:00 amRNSContract win with leading healthcare provider
8th Oct 20207:00 amRNSCompetitive contract win with major UK Retailer
29th Sep 20207:00 amRNSInterim Results
21st Sep 20207:00 amRNSNotice of Results
16th Jun 202012:00 pmRNSResult of AGM
15th May 20207:00 amRNSFinal Results
8th Apr 20207:00 amRNSCOVID-19 Update and Contract Renewal
17th Mar 20207:00 amRNSContract win with major regional Ambulance Service
24th Feb 20203:46 pmRNSHolding(s) in Company
20th Feb 20207:00 amRNSContract win with major regional NHS Trust
20th Feb 20207:00 amRNSContract win with major regional NHS Trust
14th Jan 20207:00 amRNSTrading Update
11th Dec 20197:00 amRNSLaunch of Privileged Endpoint Manager solution
14th Nov 20195:25 pmRNSHolding(s) in Company
31st Oct 201910:48 amRNSTotal Voting Rights
30th Oct 201911:35 amRNSHolding(s) in Company
29th Oct 201912:09 pmRNSHolding(s) in Company
22nd Oct 20197:00 amRNSResult of fundraise
21st Oct 20197:00 amRNSProposed fundraise
10th Oct 20197:00 amRNSNew customer and upsell contract wins
23rd Sep 20197:00 amRNSSubstantial contract win
18th Sep 20197:00 amRNSHalf Year Report
10th Sep 20191:27 pmRNSNotice of Results
14th Aug 20197:00 amRNSFirst contract win for Opus
7th Aug 20197:00 amRNSContract wins
8th Jul 20197:00 amRNSTrading update
13th Jun 201912:07 pmRNSResult of AGM
6th Jun 20197:00 amRNSContract win
4th Jun 20197:00 amRNSInfosecurity Europe 2019
29th May 20197:00 amRNSHolding(s) in Company
17th May 20197:00 amRNSContract Extension
8th May 20197:00 amRNSFinal Results
1st May 20197:00 amRNSLaunch of secure IT Process Automation solution
29th Apr 20197:00 amRNSNotice of Final Results
18th Apr 20194:05 pmRNSHolding(s) in Company
22nd Mar 20194:30 pmRNSHolding(s) in Company
27th Feb 20197:00 amRNSContract wins
12th Feb 20197:00 amRNSContract win
14th Jan 20197:00 amRNSTrading Update
9th Jan 20191:59 pmRNSHolding(s) in Company
8th Jan 20197:00 amRNSContract win with major Business Energy player
19th Dec 20187:00 amRNSContract win with Financial Services provider
5th Oct 20187:00 amRNSGrant of options and PDMR dealings
25th Sep 20187:00 amRNSInterim results
21st Sep 20187:00 amRNSContract win with UK Fashion and Homeware Retailer
19th Sep 20187:00 amRNSStrategic Technology Partnership with RazorSecure
6th Aug 20187:00 amRNSNotice of Interim Results
24th May 201811:31 amRNSResult of AGM
14th May 201810:39 amRNSHolding(s) in Company
24th Apr 20187:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.